Financhill
Back

TransMedics Group Quote, Financials, Valuation and Earnings

TransMedics Group Price Quote

$164.93
-0.07 (-0.64%)
(Updated: September 21, 2024 at 5:42 AM ET)

TransMedics Group Key Stats

Buy
69
TransMedics Group (TMDX) is a Buy

Day range:
$161.87 - $169.29
52-week range:
$36.42 - $177.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.55
P/B ratio:
28.95%

Volume:
1.2M
Avg. volume:
817.5K
1-year change:
187.11%
Market cap:
$5.5B
Revenue:
$241.6M
EPS:
$0.04

How Much Does TransMedics Group Make?

Is TransMedics Group Growing As A Company?

  • What Is TransMedics Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.18%
  • What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TransMedics Group Stock Price Performance

  • Did TransMedics Group Stock Go Up Last Month?
    TransMedics Group share price went down by -0.71% last month
  • Did TMDX's Share Price Rise Over The Last Year?
    TMDX share price rose by 187.11% over the past 1 year

What Is TransMedics Group 52-Week High & Low?

TransMedics Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TransMedics Group?

  • How Much Debt Does TransMedics Group Have?
    Total long term debt quarterly is $507.8M
  • How Much Cash Does TransMedics Group Have?
    Cash and short term investments quarterly total is $362.8M
  • What Is TransMedics Group’s Book Value Per Share?
    Book value per share is 5.70

Is TransMedics Group Cash Flow Positive?

  • What Is TMDX Cash Flow From Operations?
    Cash flow from operations (TTM) is $23.7M
  • What Is TransMedics Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $16.3M
  • What Is TransMedics Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$259.6M

TransMedics Group Return On Invested Capital

  • Is Management Doing A Good Job?
    TMDX return on invested capital is 0.46%
  • What Is TransMedics Group Return On Assets?
    ROA measures how assets are converting to revenues and is 0.42%
  • What Is TMDX Return On Equity?
    ROE is a measure of profitability and is 1.98%

TransMedics Group Earnings Date & Stock Price

TransMedics Group Competitors

TransMedics Group Dividend Yield

TransMedics Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 71.55%
Revenue: 117.87% 15.51%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 179.63
Upside from Last Price: 8.86%

Major Shareholders

  • How many TMDX shares are owned by institutional investors?
    313M TMDX shares are owned by institutional investors
  • How many TMDX shares are owned by insiders?
    469K TMDX shares are owned by insiders